BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 11207362)

  • 1. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.
    Kornak U; Kasper D; Bösl MR; Kaiser E; Schweizer M; Schulz A; Friedrich W; Delling G; Jentsch TJ
    Cell; 2001 Jan; 104(2):205-15. PubMed ID: 11207362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.
    Stauber T; Wartosch L; Vishnolia S; Schulz A; Kornak U
    Bone; 2023 Mar; 168():116639. PubMed ID: 36513280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts.
    Okamoto F; Kajiya H; Toh K; Uchida S; Yoshikawa M; Sasaki S; Kido MA; Tanaka T; Okabe K
    Am J Physiol Cell Physiol; 2008 Mar; 294(3):C693-701. PubMed ID: 18234851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
    Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
    Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.
    Kasper D; Planells-Cases R; Fuhrmann JC; Scheel O; Zeitz O; Ruether K; Schmitt A; Poët M; Steinfeld R; Schweizer M; Kornak U; Jentsch TJ
    EMBO J; 2005 Mar; 24(5):1079-91. PubMed ID: 15706348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration.
    Zhao Q; Wei Q; He A; Jia R; Xiao Y
    Biochem Biophys Res Commun; 2009 Jul; 384(3):277-9. PubMed ID: 19393632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation.
    Weinert S; Jabs S; Supanchart C; Schweizer M; Gimber N; Richter M; Rademann J; Stauber T; Kornak U; Jentsch TJ
    Science; 2010 Jun; 328(5984):1401-3. PubMed ID: 20430974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants.
    Di Zanni E; Palagano E; Lagostena L; Strina D; Rehman A; Abinun M; De Somer L; Martire B; Brown J; Kariminejad A; Balasubramaniam S; Baynam G; Gurrieri F; Pisanti MA; De Maggio I; Abboud MR; Chiesa R; Burren CP; Villa A; Sobacchi C; Picollo A
    J Bone Miner Res; 2021 Mar; 36(3):531-545. PubMed ID: 33125761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ClC-7 Regulates the Pattern and Early Development of Craniofacial Bone and Tooth.
    Zhang Y; Ji D; Li L; Yang S; Zhang H; Duan X
    Theranostics; 2019; 9(5):1387-1400. PubMed ID: 30867839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative splicing variant in Clcn7-/- mice prevents osteopetrosis but not neural and retinal degeneration.
    Rajan I; Read R; Small DL; Perrard J; Vogel P
    Vet Pathol; 2011 May; 48(3):663-75. PubMed ID: 20448277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Lysosomal Cl
    Zifarelli G
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function.
    Lange PF; Wartosch L; Jentsch TJ; Fuhrmann JC
    Nature; 2006 Mar; 440(7081):220-3. PubMed ID: 16525474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl
    Bose S; de Heus C; Kennedy ME; Wang F; Jentsch TJ; Klumperman J; Stauber T
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the bone phenotype in ClC-7-deficient mice.
    Neutzsky-Wulff AV; Karsdal MA; Henriksen K
    Calcif Tissue Int; 2008 Dec; 83(6):425-37. PubMed ID: 18958510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Null mutation of chloride channel 7 (Clcn7) impairs dental root formation but does not affect enamel mineralization.
    Guo J; Bervoets TJ; Henriksen K; Everts V; Bronckers AL
    Cell Tissue Res; 2016 Feb; 363(2):361-70. PubMed ID: 26346547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe developmental bone phenotype in ClC-7 deficient mice.
    Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
    Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.
    Henriksen K; Gram J; Schaller S; Dahl BH; Dziegiel MH; Bollerslev J; Karsdal MA
    Am J Pathol; 2004 May; 164(5):1537-45. PubMed ID: 15111300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
    Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
    J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.